CD8A and metastatic melanoma: Remarkably, TCF7, as well as other genes related to the activation and survival of CD8+ T cells, were enriched in tumor biopsies obtained from patients with metastatic melanoma responding to ICB treatment (Sade-Feldman et al. 2019).